Embecta Corp.
EMBC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001872789
In the last 90 days, Embecta Corp. insiders filed 4 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $164.6M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Embecta Corp. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 37 | 1 | 484 | +448 |
| Shares | 3.77M | 103 | 54.7M | +50.9M (+1,349.1%) |
| Value | $116.0M | $3.00K | $1.38B | +$1.27B (+1,093.6%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (455)
Institutions that held Embecta Corp. at the end of Q2 2022 but not at the end of Q1 2022.
Showing the largest 100 of 455 by value.
Sold out (7)
Institutions that held Embecta Corp. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| J. Goldman & Co LP | 45,350 | $1.51M |
| Mitsubishi UFJ Trust & Banking Corp | 36,957 | $1.23M |
| Newtyn Management, LLC | 21,366 | $712.0K |
| Walleye Capital LLC | 10,161 | $339.0K |
| Paladin Advisory Group, LLC | 101 | $3.00K |
| Icapital Wealth LLC | 22 | $647 |
| Bluefin Capital Management, LLC | 10,756 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Embecta Corp. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Lenox Wealth Advisors, LLC | 103 | $3.00K |